Dillman, R O <br/><br/>
Clinical experience with autologous tumor cell lines for patient-specific vaccine therapy in metastatic melanoma.  [electronic resource] 

 -  Cancer biotherapy & radiopharmaceuticals  Jun 1998 
 - 165-76 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1084-9785 
<br/><br/><label>Standard No.: </label>10.1089/cbr.1998.13.165  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>BCG Vaccine--therapeutic use<br/>Cancer Vaccines--adverse effects<br/>Cell Culture Techniques--methods<br/>Cell Line<br/>Disease-Free Survival<br/>Granulocyte-Macrophage Colony-Stimulating Factor--therapeutic use<br/>Humans<br/>Hypersensitivity, Delayed<br/>Interferons--therapeutic use<br/>Melanoma--immunology<br/>Survival Rate<br/>Tumor Cells, Cultured